Leucine-Enriched Ketogenic Formulation for Intractable Epilepsy
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Intractable epilepsy patients often do not respond adequately to antiepileptic drugs (AEDs) or ketogenic diets, necessitating alternative therapeutic options to manage seizures effectively.
Innovation Solution
A ketogenic composition comprising a non-casein protein source and a leucine-enriched amino acid mixture, which enhances leucine availability, protein synthesis, and glutamate dehydrogenase expression, is administered to subjects, either alone or in conjunction with a ketogenic diet, to reduce or inhibit seizures by stimulating ATP production and anaplerosis in low glucose conditions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If a standard ketogenic diet is administered to patients with intractable epilepsy, then seizure reduction is achieved in some patients, but complete symptom resolution is not achieved in all patients
Solution Approach 1:
The patent modifies the ketogenic diet by changing the amino acid composition parameters - specifically enriching the formula with leucine and other branched-chain amino acids while maintaining the ketogenic ratio. This parameter change aims to enhance protein synthesis and metabolic flexibility to achieve complete seizure resolution in patients who did not respond to standard KD alone.
2Productivity
If protein intake is increased to enhance protein synthesis, then anabolic effects are improved, but ketone body production may be compromised
Solution Approach 1:
The patent optimizes the balance between protein and fat macronutrients by adjusting the ketogenic ratio (typically 4:1 or higher) while incorporating leucine-enriched amino acid mixtures. This allows sufficient protein intake for anabolic effects without compromising ketone production, as the high fat content maintains ketone availability despite increased protein consumption.
Solution Approach 2:
The patent introduces leucine-enriched amino acid mixtures as intermediary substances that mediate between protein synthesis requirements and ketone body needs. These amino acids act as intermediaries that can be utilized for protein synthesis while also serving as substrates for ketone body formation, thus resolving the conflict between anabolic and ketogenic effects.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The described ketogenic composition significantly reduces epileptic seizures in subjects refractory to AEDs and ketogenic diets by enhancing the metabolic shift towards ketone bodies as energy substrates, providing intermediary co-factors for the TCA cycle and promoting protein synthesis, thereby offering a therapeutic benefit for intractable epilepsy and other metabolic disorders.
Implementation Method 1
enhance leucine availability, protein synthesis, and/or glutamate dehydrogenase expression, activity, or availability
Implementation Method 2
enhancing the metabolic shift towards ketone bodies as energy substrates, providing intermediary co-factors for the TCA cycle
Implementation Method 3
stimulating ATP production and anaplerosis in low glucose conditions
Data Source
AI summary
Described herein are nutritional compositions, such as ketogenic compositions, leucine-enriched amino acid mixtures, etc., useful, for example, for dietary management of intractable epilepsy. In some embodiments, the disclosure relates to methods of inhibiting epileptic seizures in a subject comprising administering to the subject a leucine-enriched amino acid mixture.